MedElevator
Войти в исследования Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition · 2026
Exclusive enteral nutrition improves radiological outcomes in adults with perianal fistulizing Crohn's disease: A real-world retrospective cohort study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Deng Xiaoxia, Huang Zicheng, Xia Qiuyue, Huang Zhaopeng, Wu Yue, Wu Yanhui, Li Qing, Diao Na, Li Miao, Tang Jian, Guo Qin, Gao Xiang, Yang Qing Fan, Chao Kang
Аннотация
BACKGROUND: Exclusive enteral nutrition (EEN) is effective in luminal Crohn's disease (CD). However, its role in perianal fistulizing Crohn's disease (PFCD) remains unclear. This study aimed to evaluate the radiological and clinical outcomes of EEN in adult patients with PFCD.
METHODS: This retrospective real-world cohort study included adult CD patients with draining perianal fistulas, as confirmed by magnetic resonance imaging (MRI). All patients received EEN for 8-12 weeks between January 2015 and December 2024. Pelvic MRI was performed before and after EEN. The primary endpoint was radiological healing. The secondary endpoints included radiological improvement, clinical fistula response and remission, overall clinical response and remission, endoscopic response and remission, C-reactive protein (CRP) remission, and reductions in Van Assche Index (VAI) and modified VAI (m-VAI) from baseline.
RESULTS: Among 152 patients, radiological healing was observed in 12.5% of patients, with radiological improvement in 77.6% of cases. Clinical fistula response and remission were achieved in 55.9% and 47.4% of patients, respectively. After treatment, both VAI (12.0 [8.0, 15.0] vs 8.0 [6.0, 11.0], p < 0.001) and m-VAI (9.0 [7.0, 12.8] vs 7.0 [4.3, 9.0], p < 0.001) significantly decreased. Overall clinical response and remission were observed in 73.0% and 24.3% of patients, respectively. Endoscopic response and remission occurred in 79.6% and 40.8% of patients, respectively. CRP remission was observed in of 77.6% patients. Concomitant antibiotics (odds ratio, 3.06; 95% confidence interval, 1.21-7.72; p = 0.018) were independently associated with radiological improvement.
CONCLUSIONS: EEN treatment was associated with improved radiological and clinical outcomes in patients with PFCD.
METHODS: This retrospective real-world cohort study included adult CD patients with draining perianal fistulas, as confirmed by magnetic resonance imaging (MRI). All patients received EEN for 8-12 weeks between January 2015 and December 2024. Pelvic MRI was performed before and after EEN. The primary endpoint was radiological healing. The secondary endpoints included radiological improvement, clinical fistula response and remission, overall clinical response and remission, endoscopic response and remission, C-reactive protein (CRP) remission, and reductions in Van Assche Index (VAI) and modified VAI (m-VAI) from baseline.
RESULTS: Among 152 patients, radiological healing was observed in 12.5% of patients, with radiological improvement in 77.6% of cases. Clinical fistula response and remission were achieved in 55.9% and 47.4% of patients, respectively. After treatment, both VAI (12.0 [8.0, 15.0] vs 8.0 [6.0, 11.0], p < 0.001) and m-VAI (9.0 [7.0, 12.8] vs 7.0 [4.3, 9.0], p < 0.001) significantly decreased. Overall clinical response and remission were observed in 73.0% and 24.3% of patients, respectively. Endoscopic response and remission occurred in 79.6% and 40.8% of patients, respectively. CRP remission was observed in of 77.6% patients. Concomitant antibiotics (odds ratio, 3.06; 95% confidence interval, 1.21-7.72; p = 0.018) were independently associated with radiological improvement.
CONCLUSIONS: EEN treatment was associated with improved radiological and clinical outcomes in patients with PFCD.